AARP, Others Bash AstraZeneca's Drug Pricing Challenge
Nine health care experts and the AARP in briefs filed Thursday asked a Delaware federal court to reject AstraZeneca's challenge to the Inflation Reduction Act's provision allowing the government to negotiate...To view the full article, register now.
Already a subscriber? Click here to view full article